Exagen Inc (XGN)
1.895
0.00 (0.00%)
USD |
NASDAQ |
May 17, 16:00
1.895
0.00 (0.00%)
After-Hours: 20:00
Exagen Shareholders Equity (Quarterly): 19.99M for March 31, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 19.99M |
December 31, 2023 | 22.69M |
September 30, 2023 | 27.50M |
June 30, 2023 | 31.90M |
March 31, 2023 | 35.94M |
December 31, 2022 | 42.46M |
September 30, 2022 | 56.19M |
June 30, 2022 | 64.18M |
March 31, 2022 | 76.16M |
December 31, 2021 | 84.94M |
September 30, 2021 | 90.80M |
June 30, 2021 | 96.38M |
March 31, 2021 | 101.47M |
December 31, 2020 | 41.84M |
September 30, 2020 | 44.47M |
Date | Value |
---|---|
June 30, 2020 | 47.84M |
March 31, 2020 | 50.54M |
December 31, 2019 | 55.66M |
September 30, 2019 | 58.65M |
June 30, 2019 | -0.708M |
December 31, 2018 | -6.734M |
December 31, 2015 | -22.18M |
September 30, 2015 | -18.61M |
June 30, 2015 | -15.64M |
March 31, 2015 | -17.08M |
December 31, 2014 | -14.06M |
September 30, 2014 | -11.65M |
June 30, 2014 | -7.055M |
December 31, 2013 | 0.451M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
-0.708M
Minimum
Jun 2019
101.47M
Maximum
Mar 2021
52.44M
Average
49.19M
Median
Shareholders Equity (Quarterly) Benchmarks
Fonar Corp | 165.76M |
XWELL Inc | 13.00M |
ProPhase Labs Inc | 44.87M |
Applied DNA Sciences Inc | -0.0481M |
Veracyte Inc | 1.119B |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 50.81M |
Total Liabilities (Quarterly) | 30.82M |
Debt to Equity Ratio | 0.9773 |
Current Ratio | 4.828 |
Net Debt Paydown Yield | 6.85% |